(Q39006642)

8 September 2017

Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study (English)

1 reference

8 September 2017

0 references

11

EuroSIDA Study Group

1 reference

8 September 2017

J Lundgren

2

0 references

Christine Katlama

8

object named as

C Katlama

1 reference

8 September 2017

5

O Kirk

1 reference

8 September 2017

E Florence

1

1 reference

8 September 2017

C Dreezen

3

1 reference

8 September 2017

M Fisher

4

1 reference

8 September 2017

A Blaxhult

6

1 reference

8 September 2017

G Panos

7

1 reference

8 September 2017

S Vella

9

1 reference

8 September 2017

A Phillips

10

1 reference

8 September 2017

1 July 2003

1 reference

8 September 2017

1 reference

8 September 2017

4

1 reference

8 September 2017

3

1 reference

8 September 2017

255-262

1 reference

Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection.

8 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

AIDS across Europe, 1994-98: the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Interference with cell cycle progression and induction of apoptosis by dideoxynucleoside analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Possible mechanism of toxicity of zidovudine by induction of apoptosis of CD4+ and CD8+ T-cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Lack of immunotoxicity of saquinavir (Ro 31-8959) used alone or in double or triple combination with AZT and ddC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00156.X

10.1046/J.1468-1293.2003.00156.X

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference